title: Induction of erythroid differentiation in human erythroleukemia cells by depletion of malic enzyme 2.
abstract: Malic enzyme 2 (ME2) is a mitochondrial enzyme that catalyzes the conversion of malate to pyruvate and CO2 and uses NAD as a cofactor. Higher expression of this enzyme correlates with the degree of cell de-differentiation. We found that ME2 is expressed in K562 erythroleukemia cells, in which a number of agents have been found to induce differentiation either along the erythroid or the myeloid lineage. We found that knockdown of ME2 led to diminished proliferation of tumor cells and increased apoptosis in vitro. These findings were accompanied by differentiation of K562 cells along the erythroid lineage, as confirmed by staining for glycophorin A and hemoglobin production. ME2 knockdown also totally abolished growth of K562 cells in nude mice. Increased ROS levels, likely reflecting increased mitochondrial production, and a decreased NADPH/NADP+ ratio were noted but use of a free radical scavenger to decrease inhibition of ROS levels did not reverse the differentiation or apoptotic phenotype, suggesting that ROS production is not causally involved in the resultant phenotype. As might be expected, depletion of ME2 induced an increase in the NAD+/NADH ratio and ATP levels fell significantly. Inhibition of the malate-aspartate shuttle was insufficient to induce K562 differentiation. We also examined several intracellular signaling pathways and expression of transcription factors and intermediate filament proteins whose expression is known to be modulated during erythroid differentiation in K562 cells. We found that silencing of ME2 leads to phospho-ERK1/2 inhibition, phospho-AKT activation, increased GATA-1 expression and diminished vimentin expression. Metabolomic analysis, conducted to gain insight into intermediary metabolic pathways that ME2 knockdown might affect, showed that ME2 depletion resulted in high orotate levels, suggesting potential impairment of pyrimidine metabolism. Collectively our data point to ME2 as a potentially novel metabolic target for leukemia therapy.
authors.affiliation: Divisions of Interdisciplinary Medicine and Biotechnology, Hematology-Oncology and Nephrology, Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School, Boston, Massachusetts, United States of America.
authors.forename: Jian-Guo
authors.initials: JG
authors.lastname: Ren
authors.forename: Pankaj
authors.initials: P
authors.lastname: Seth
authors.forename: Peter
authors.initials: P
authors.lastname: Everett
authors.forename: Clary B
authors.initials: CB
authors.lastname: Clish
authors.forename: Vikas P
authors.initials: VP
authors.lastname: Sukhatme
mesh_terms: D000818:Animals; D017209:Apoptosis; D002454:Cell Differentiation; D049109:Cell Proliferation; D041905:Erythroid Cells / Q000166:cytology* / Q000201:enzymology*; D055786:Gene Knockout Techniques; D006801:Humans; D020014:K562 Cells; D004915:Leukemia, Erythroblastic, Acute / Q000201:enzymology* / Q000235:genetics / Q000503:physiopathology*; D008291:Malate Dehydrogenase / Q000172:deficiency* / Q000235:genetics; D051379:Mice
chemical_list: D008291:Malate Dehydrogenase; C495394:malic enzyme 2; human
references.citation: Blood. 2000 Apr 1;95(7):2391-6
references.pmid: 10733512
references.citation: Science. 1997 Mar 14;275(5306):1649-52
references.pmid: 9054359
references.citation: J Biol Chem. 2007 Dec 7;282(49):35657-65
references.pmid: 17928289
references.citation: Nat Methods. 2006 Sep;3(9):715-9
references.pmid: 16929317
references.citation: Int J Biochem Cell Biol. 2009 Mar;41(3):570-7
references.pmid: 18694847
references.citation: Nat Med. 1996 May;2(5):561-6
references.pmid: 8616716
references.citation: Blood. 2009 May 7;113(19):4512-20
references.pmid: 19066393
references.citation: J Biol Chem. 2007 Jan 5;282(1):200-7
references.pmid: 17102138
references.citation: Blood. 2000 Sep 15;96(6):2284-91
references.pmid: 10979978
references.citation: Cancer Lett. 1985 Aug;28(1):35-42
references.pmid: 4027954
references.citation: Leuk Res. 2004 Jun;28(6):623-9
references.pmid: 15120940
references.citation: Cancer Cell. 2005 Oct;8(4):311-21
references.pmid: 16226706
references.citation: Biochem Biophys Res Commun. 1973 Jan 23;50(2):524-31
references.pmid: 4144006
references.citation: Nature. 2006 May 25;441(7092):451-6
references.pmid: 16724057
references.citation: Toxicol In Vitro. 2008 Sep;22(6):1503-10
references.pmid: 18586450
references.citation: Mol Pharmacol. 2002 Sep;62(3):463-72
references.pmid: 12181422
references.citation: J Biol Chem. 1979 Apr 25;254(8):2669-76
references.pmid: 429309
references.citation: Cancer Res. 1969 Jun;29(6):1195-9
references.pmid: 4307782
references.citation: Biochem Biophys Res Commun. 1999 Oct 5;263(3):790-6
references.pmid: 10512759
references.citation: J Biol Chem. 1980 May 10;255(9):3844-8
references.pmid: 7372652
references.citation: Am J Hum Genet. 2005 Jan;76(1):139-46
references.pmid: 15532013
references.citation: Am J Pathol. 2009 Mar;174(3):1017-26
references.pmid: 19179610
references.citation: J Biol Chem. 2006 Oct 13;281(41):30593-602
references.pmid: 16912049
references.citation: Leuk Res. 1995 Apr;19(4):263-73
references.pmid: 7538618
references.citation: Mol Cell. 2002 May;9(5):1031-44
references.pmid: 12049739
references.citation: FASEB J. 2003 Nov;17(14):2160-2
references.pmid: 14597677
references.citation: Cancer Res. 1988 Feb 1;48(3):602-8
references.pmid: 3335023
references.citation: Biochimie. 1992 Nov;74(11):959-74
references.pmid: 1477140
references.citation: Biochem Pharmacol. 1990 Feb 1;39(3):455-62
references.pmid: 1968339
references.citation: Free Radic Biol Med. 2008 Apr 15;44(8):1529-35
references.pmid: 18275858
references.citation: Oncogene. 2006 Feb 2;25(5):781-94
references.pmid: 16186797
references.citation: J Chromatogr A. 2007 Apr 20;1147(2):153-64
references.pmid: 17376459
references.citation: Biochem J. 1990 Jan 15;265(2):503-9
references.pmid: 2302181
references.citation: Annu Rev Biochem. 1979;48:871-922
references.pmid: 38739
references.citation: J Cell Physiol. 1990 May;143(2):310-20
references.pmid: 1692028
references.citation: Mol Cell Biochem. 2004 Mar;258(1-2):25-33
references.pmid: 15030167
references.citation: J Biol Chem. 2008 Nov 7;283(45):30461-70
references.pmid: 18687678
references.citation: Blood. 2000 Oct 1;96(7):2440-50
references.pmid: 11001896
references.citation: J Biol Chem. 1984 May 25;259(10):6215-21
references.pmid: 6144677
references.citation: Nat Rev Cancer. 2007 Oct;7(10):763-77
references.pmid: 17882277
references.citation: Biochem Pharmacol. 2006 Sep 14;72(6):671-80
references.pmid: 16828058
references.citation: J Cell Physiol. 2004 Mar;198(3):370-6
references.pmid: 14755542
references.citation: Cancer Res. 1986 Nov;46(11):5589-91
references.pmid: 3756905
references.citation: Tissue Cell. 2002 Feb;34(1):33-8
references.pmid: 11989968
references.citation: Biol Reprod. 2009 Feb;80(2):295-301
references.pmid: 18971426
references.citation: Mol Cell Biol. 2009 Mar;29(5):1163-75
references.pmid: 19103751
references.citation: Cell Biol Int. 1998;22(1):41-9
references.pmid: 9828081
references.citation: J Biol Chem. 2000 Aug 11;275(32):24273-8
references.pmid: 10833515
references.citation: CRC Crit Rev Biochem. 1981;11(4):341-93
references.pmid: 6118236
references.citation: Physiol Genomics. 2004 Apr 13;17(2):140-9
references.pmid: 14747661
references.citation: Psychiatry Res. 2007 Feb 28;150(1):1-11
references.pmid: 17258816
references.citation: Cancer Cell. 2006 Sep;10(3):241-52
references.pmid: 16959615
references.citation: J Cell Physiol. 1989 May;139(2):370-6
references.pmid: 2715192
references.citation: J Biol Chem. 2001 Jan 5;276(1):522-8
references.pmid: 11016926
references.citation: Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10465-9
references.pmid: 17563371
references.citation: J Biol Chem. 2001 Apr 20;276(16):13186-91
references.pmid: 11278385
references.citation: Cell Biol Int. 2004;28(5):403-10
references.pmid: 15193284
references.citation: J Biol Chem. 1991 Feb 15;266(5):3016-21
references.pmid: 1993674
references.citation: Cell Growth Differ. 2001 Sep;12(9):481-6
references.pmid: 11571231
references.citation: Leuk Res. 1995 Mar;19(3):203-12
references.pmid: 7700081
references.citation: Biochemistry. 2005 Sep 27;44(38):12737-45
references.pmid: 16171388
references.citation: J Biol Chem. 2001 Oct 12;276(41):37747-53
references.pmid: 11489902
references.citation: FEBS Lett. 2004 Nov 19;577(3):361-6
references.pmid: 15556610
references.citation: J Biol Chem. 1980 May 10;255(9):3849-54
references.pmid: 7372653
references.citation: Eur J Cancer. 1976 Apr;12(4):299-303
references.pmid: 60240